Product image of Glucosalina (Sodium Chloride, Glucose) supplied by GNH India

Glucosalina

Active Ingredient:
Sodium Chloride, Glucose
Origin:
EU

Glucosalina (Sodium Chloride, Glucose)

Glucosalina is an intravenous solution containing sodium chloride and glucose. It is supplied in a sterile liquid form for infusion, with no specified strength listed. The product is manufactured for the European Union market and is intended for use under professional medical supervision. The formulation provides electrolytes and an energy source, and it is typically stored at controlled room temperature until administration in clinical settings by healthcare professionals.

Manufacturer / TM Owner

Laboratorios Grifols, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glucosalina is used as an intravenous fluid to support patients who require electrolyte replacement and an energy substrate during medical treatment. Its typical clinical applications include:

  • Rehydration therapy for patients with fluid loss.
  • Maintenance of plasma volume during surgery.
  • Supplementation of sodium and chloride in patients with electrolyte imbalance.
  • Provision of glucose for patients unable to intake oral carbohydrates.
  • Dilution and carrier solution for intravenous drug administration.

Side Effects

Potential adverse effects of Glucosalina may vary in frequency and severity. Reported events are categorized as common or serious based on clinical observations.

Common

  • Mild injection site irritation or redness.
  • Transient nausea or vomiting.
  • Temporary increase in blood glucose levels.

Serious

  • Hypernatremia or electrolyte imbalance.
  • Severe allergic reaction such as anaphylaxis.
  • Fluid overload leading to pulmonary edema.

Precautions & Warnings

When considering Glucosalina, clinicians should evaluate patient-specific factors and follow standard infusion guidelines to minimize risk.

  • Assess baseline electrolyte levels and renal function before administration.
  • Monitor blood glucose and serum sodium during infusion.
  • Adjust infusion rate in patients with heart failure or pulmonary edema risk.
  • Avoid rapid infusion in neonates and infants.
  • Use aseptic technique to prevent contamination.
  • Discontinue if signs of allergic reaction appear.

Avoid Interactions

Glucosalina may interact with other intravenous solutions or medications, influencing electrolyte balance or glucose metabolism.

Avoid

  • Co-administration with hypertonic saline solutions without adjusting total sodium load.
  • Simultaneous infusion of high-concentration dextrose solutions that could cause hyperglycemia.

Use with caution

  • Concurrent use of diuretics that affect sodium balance.
  • Patients receiving insulin therapy, requiring close glucose monitoring.
  • Administration alongside nephrotoxic drugs, monitoring renal function.

Frequently Asked Questions

Glucosalina contains sodium chloride and glucose dissolved in a sterile aqueous carrier, formulated for intravenous infusion.

It is commonly used for fluid resuscitation, electrolyte replacement, glucose supplementation, and as a diluent for other IV medications.

The solution should be kept at controlled room temperature, protected from light, and used before the expiration date indicated on the packaging.

Patients should have regular checks of serum sodium, chloride, glucose levels, and overall fluid balance throughout the infusion.

Use in neonates and infants requires careful rate adjustment and close monitoring; consult pediatric dosing guidelines before administration.

Common reactions include mild injection site irritation, transient nausea, vomiting, and temporary elevations in blood glucose.

Signs of hypernatremia, severe allergic reactions such as anaphylaxis, or fluid overload leading to pulmonary edema require immediate cessation.

Glucosalina should be avoided in patients with known hypersensitivity to its components or in conditions where excess sodium or glucose could be harmful.

Diuretics may alter sodium balance; when used together, electrolyte levels should be closely monitored and infusion rates adjusted as needed.

Renal function should be assessed before infusion, and the volume and rate of administration may need modification to prevent fluid overload.

Compatibility depends on the total sodium and glucose load; avoid mixing with hypertonic saline or high‑concentration dextrose solutions without proper adjustment.

Standard medication administration records should include product name, concentration, infusion rate, patient monitoring parameters, and any observed reactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Sodium Chloride, Glucose

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT